Member Info for jange

The Wholesale and Distribution Divisions have benefited from the availability of a wider product set and have seen an improvement in cross selling trends among much of their product portfolios. The chance to cross-sell was one of the reasons why the group bought Worldwide Group Holdings, which has a complementary product set to Daisy, including data connectivity, inbound-telephony, international toll-free services, maintenance services and disaster recovery.

The acquisitive company, which also announced the £28m purchase of audio-conferencing specialist Worldwide Group Holdings, said its focus in the year just ended shifted to integrating the companies it has purchased in the last 18 months, and declared itself pleased with its progress in this area. The group's Retail division made progress with its mobile and data product portfolios which partially offset the expected tail-off in fixed line call revenues. The division has seen a "moderate lengthening" of sales cycles for some larger contracts, particularly in systems and large data installations.

Gareth Kirkwood, the Chief Operating Officer of business communications services provider Daisy Group, has quit the board with immediate effect. Kirkwood will leave the group at the end of the month to pursue other interests. His duties will be assumed by Daisy's Chief Executive Officer, Matthew Riley. The departure was announced along with the group's pre-close statement which revealed that profit and earnings for the year ending March 2012 are expected to be within the range of market forecasts

Nightmare Scenario: With Experian shares near the top of their 52 week range, too much of the growth story may already be in the price.

Trade Summary Dream Scenario: Experian remains highly regarded as an emerging markets growth play.

Key Technicals Shares of Experian have occupied a very steady looking rising trend channel on the daily chart since the end of October. The floor of the channel runs level with the current position of the 50-day moving average at 950p - and while this double support remains in place the upside for the stock should be the late 2011 price channel top as high as 1,020p.

Not only are annual profits at Experian predicted to almost double over the next 3 years, but since the Q3 announcement in January, acquisitions have been announced in Japan and the U.S. which are set to underpin profits still further. The breakneck speed of international expansion has marked the group out as a proxy to emerging market growth, and quite deservedly puts the stock at the top of the Galvan Research buy list.

On January 17th, credit-checking firm Experian announced it had achieved underlying revenue growth in all geographic sectors in the final quarter of 2011, lead by Latin America. In the three months to 31 Dec 2011 total revenue from continuing activities increased by 12% at constant exchange rates from the year before. Group organic revenue growth was 7% year-on-year. Organic revenue growth was 15% at Credit Services, 3% at Decision Analytics, and 7% at Marketing Services. Organic revenue declined 1% at Interactive. Latin America's organic growth was 27%, while both the UK & Ireland and the Europe, Middle East, Africa / Asia Pacific regional groups delivered 7% growth. North America's underlying revenue growth was 2%.

SABMiller (SAB), especially in the wake of the recent Foster’s purchase where news as to how the new acquisition is bedding in is eagerly awaited. In fact, at the end of February, Nomura was happy to downgrade the shares on the basis that too much of the benefit of the Australian purchase was already in the price. But with EU zone worries currently to the fore it may be that Jefferies early April price target hike from 2,725p to 2,850p on the back of SAB’s emerging markets growth attractions is the view that wins the day in the wake of the forthcoming trading announcement.

Marks & Spencer (MKS) will be aiming to prove that the steady Christmas performance which left broker recommendations and profits forecasts on the stock unchanged, was the correct way to go. In fact, the bias both on the stock price and the fundamental front has been to the upside since then, culminating in broker UBS raising its full-year pre-tax profit forecast by 3% to £690m and hiking the target price from 325p to 410p at the end of February

Havent posted for a while here,but im still invested this is one for the future imho

"Despite significantly increased investment in capital expenditures and other areas of the business, cash generation continues to be strong with a net cash position again reported at the year end, ahead of market expectations.

In a statement the firm said: "Whilst economic conditions are expected to continue to be challenging in FY2013, the board is confident that on-going investments, particularly in the areas of sales, operations and technology, will enable the business to deliver continued growth in revenues, margins and profit in line with management's expectations.

Consequently, overall fourth quarter group revenue was down slightly on the same period last year, but still up almost 6% for the year as a whole. However, exceptional start-up costs have been winding down meaning costs for the full year are at the lower end of the $5-6m range previously announced. Excluding start-up costs, normalised gross margin in the fourth quarter was "modestly" above management's stated objective of exiting the year at around 20%. As a result, full year normalised operating profit will be slightly ahead of market expectations for the year ended April 1st.

Electrical, digital and optical connections provider Volex has reported 'resilient' trading in the final quarter despite continuing economic uncertainty. Consumer revenue was in line with the previous year, while year-on-year revenue growth in the Healthcare sector was over 20%. Telecoms/Datacoms revenue in the quarter continued to be affected by reduced spend by telecoms operators while trading in the Industrial sector, as predicted, largely recovered from the customer destocking experienced in the third quarter.

The operating margin has continued to improve, which the firm says is benefitting from the self help measures of higher quality revenues, efficiency and cost reduction. Cash at the end of the year was £6.7m following the acquisition of WEBTEC for $30m.

Scapa Group, a manufacturer of bonding materials and solutions, has reported a good second half to the year ended March 31st, resulting in both operating profit and profit before tax being significantly ahead of both last year's results and market expectations.

"The board maintains the view that overall revenues will show similar year on year growth in the new financial year with the decline in manual vitamin D test volumes combined with more competitive pricing being offset by increased IDS-iSYS revenues as a result of new placements and an increasing number of automated tests becoming available."

In a statement the company said: "Investment in new product development to expand the range of automated IDS-iSYS tests will increase in the current financial year and beyond. The board believes that IDS-iSYS' portfolio of specialised assay panels provides the group with an attractive market opportunity with appeal to a range of laboratories which will be enhanced as further assays are launched. As a consequence the board expects the volume of IDS-iSYS system placements to be at a similar level in the new financial year as those achieved in the year ended March 31st 2012.

Immunodiagnostic Systems Holdings, a firm which produces specialist dianostic testing kits, has said revenue for the year is expected to be six per cent ahead of the previous year at £53.4m (2011: £50.2m), in line with previous updates. The company expects to have generated £6.9m in cash from operations during the year, with cash at the end of March at £6.8m. Borrowings decreased by £2.2m to £4.2m.